Edition of International Cancer Conference

The International Cancer Conference (ICC 2026) will serve as a significant platform for both in-person and virtual participation, under the theme 'From Prevention to Survivorship: A Cancer Care Continuum.' This conference is poised to gather leading oncologists, researchers, clinicians, healthcare professionals, industry innovators, and policymakers from around the globe to foster interdisciplinary dialogue and partnerships that could lead to innovative solutions in the fight against cancer.

Covering a broad spectrum of topics, including molecular oncology, immunotherapy, precision medicine, cancer genetics, and clinical trials, ICC 2026 aims to explore foundational research alongside translational applications. Participants can expect to engage in original research presentations, case studies, and innovative methodologies through various formats such as oral presentations, poster sessions, panel discussions, and interactive workshops.

These sessions are designed to stimulate collaboration, encourage critical discussions, and highlight pioneering approaches in cancer prevention, diagnosis, and treatment. The agenda will also feature insightful contributions from a distinguished lineup of speakers. Notable among them are experts from institutions such as the University of California San Francisco, the Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, and various hospitals and universities spanning countries like Japan, the United Kingdom, Brazil, and India.

The conference promises to unite these experts in advancing cancer research, improving patient outcomes, and fostering innovation in oncology. With a focus on areas such as Palliative Care, Supportive Oncology, and Future Directions in Cancer Research, ICC 2026 is set to pave the way for significant advancements in the field of oncology and ensure that the discussions lead to actionable insights and collaborations.